Singapore markets closed

Onconetix, Inc. (ONCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1501-0.0049 (-3.16%)
As of 02:49PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.1550
Bid0.1458 x 400
Ask0.1551 x 100
Day's range0.1414 - 0.1638
52-week range0.1000 - 1.3100
Avg. volume4,419,550
Market cap3.351M
Beta (5Y monthly)3.73
PE ratio (TTM)N/A
Earnings date20 May 2024 - 24 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

    CINCINNATI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), a commercial stage biotechnology company focused on developing and commercializing therapeutics, diagnostics, and services for clinicians and patients in oncology, today announced the appointment of Ajit Singh, Ph.D. and Thomas Meier, Ph.D. to its Board of Directors. “We are thrilled to announce the addition of Dr. Singh and Dr. Meier to the Board of Directors of Onconetix,” stated Chair